These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 30928918)

  • 1. Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials.
    Koutnikova H; Genser B; Monteiro-Sepulveda M; Faurie JM; Rizkalla S; Schrezenmeir J; Clément K
    BMJ Open; 2019 Mar; 9(3):e017995. PubMed ID: 30928918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials.
    Sáez-Lara MJ; Robles-Sanchez C; Ruiz-Ojeda FJ; Plaza-Diaz J; Gil A
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27304953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Probiotics and Synbiotics in Patients with Nonalcoholic Fatty Liver Disease: A Meta-Analysis.
    Liu L; Li P; Liu Y; Zhang Y
    Dig Dis Sci; 2019 Dec; 64(12):3402-3412. PubMed ID: 31203554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of probiotics on body adiposity and cardiovascular risk markers in individuals with overweight and obesity: A systematic review and meta-analysis of randomized controlled trials.
    Pontes KSDS; Guedes MR; Cunha MRD; Mattos SS; Barreto Silva MI; Neves MF; Marques BCAA; Klein MRST
    Clin Nutr; 2021 Aug; 40(8):4915-4931. PubMed ID: 34358838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-obese effects of two Lactobacilli and two Bifidobacteria on ICR mice fed on a high fat diet.
    Li Z; Jin H; Oh SY; Ji GE
    Biochem Biophys Res Commun; 2016 Nov; 480(2):222-227. PubMed ID: 27746173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can probiotics stop oral cancer progression?
    Kumar SS
    Evid Based Dent; 2022 Mar; 23(1):22-23. PubMed ID: 35338322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of probiotics on the treatment of non-alcoholic fatty liver disease].
    Wang W; Shi LP; Shi L; Xu L
    Zhonghua Nei Ke Za Zhi; 2018 Feb; 57(2):101-106. PubMed ID: 29397594
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of probiotic species on irritable bowel syndrome symptoms: A bring up to date meta-analysis.
    Ortiz-Lucas M; Tobías A; Saz P; Sebastián JJ
    Rev Esp Enferm Dig; 2013 Jan; 105(1):19-36. PubMed ID: 23548007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Probiotics improve obesity-associated dyslipidemia and insulin resistance in high-fat diet-fed rats].
    Yu RQ; Yuan JL; Ma LY; Qin QX; Wu XY
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Dec; 15(12):1123-7. PubMed ID: 24342213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of vitamin D supplementation on metabolic profiles and liver function in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Tabrizi R; Moosazadeh M; Lankarani KB; Akbari M; Heydari ST; Kolahdooz F; Samimi M; Asemi Z
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S975-S982. PubMed ID: 28751149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of curcumin supplementation on body mass index, body weight, and waist circumference in patients with nonalcoholic fatty liver disease: A systematic review and dose-response meta-analysis of randomized controlled trials.
    Baziar N; Parohan M
    Phytother Res; 2020 Mar; 34(3):464-474. PubMed ID: 31799714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Loman BR; Hernández-Saavedra D; An R; Rector RS
    Nutr Rev; 2018 Nov; 76(11):822-839. PubMed ID: 30113661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THE THERAPEUTIC IMPACT OF PROBIOTICS ON NONALCOHOLIC FATTY LIVER DISEASE IN PEDIATRICS: A SYSTEMATIC REVIEW.
    Chaves FGB; Oliveira GF; Ribeiro JP; Serafim JV; Cordeiro LFM; Alvares MA; Cecchi MT; Vasquez MC; Souza TBD; Rullo VEV
    Rev Paul Pediatr; 2021; 39():e2019226. PubMed ID: 32876312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose- and glycaemic factor-lowering effects of probiotics on diabetes: a meta-analysis of randomised placebo-controlled trials.
    Sun J; Buys NJ
    Br J Nutr; 2016 Apr; 115(7):1167-77. PubMed ID: 26899960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of probiotic-supplemented triple therapy for eradication of Helicobacter pylori in children: a systematic review and network meta-analysis.
    Feng JR; Wang F; Qiu X; McFarland LV; Chen PF; Zhou R; Liu J; Zhao Q; Li J
    Eur J Clin Pharmacol; 2017 Oct; 73(10):1199-1208. PubMed ID: 28681177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid and non-alcoholic fatty liver disease: Meta-analyses of case-control and randomized controlled trials.
    Guo XF; Yang B; Tang J; Li D
    Clin Nutr; 2018 Feb; 37(1):113-122. PubMed ID: 28161092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of liraglutide 3 mg vs structured lifestyle modification on body weight, liver fat and liver function in obese patients with non-alcoholic fatty liver disease: A pilot randomized trial.
    Khoo J; Hsiang J; Taneja R; Law NM; Ang TL
    Diabetes Obes Metab; 2017 Dec; 19(12):1814-1817. PubMed ID: 28503750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
    Goldenberg JZ; Lytvyn L; Steurich J; Parkin P; Mahant S; Johnston BC
    Cochrane Database Syst Rev; 2015 Dec; (12):CD004827. PubMed ID: 26695080
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.